"Pharmaceutical headlines Jun" multinational pharmaceutical companies half a year results are mixed, single drugstore how to survive?

(2020/08/03) Mercer east second quarter results: total revenue of $10.9 billion K drugs sold $3.4 billion; (Click on the title, you can get the original) "Pharmaceutical 1st Time" Mercer East second quarter results: total revenue of $10.9 billion K drug sold $3.4 billion! Mercer recently reported second-quarter 2020 sales of $10.9 billion, down 8% year-on-year, and global sales down 5% excluding foreign exchange.
pharmaceutical business revenue of $9.7 billion, down 7% year-on-year, and excluding the adverse effects of foreign exchange, sales fell 6%.
headline: Keytruda continues to penetrate the market.
(8 o'clock) Chinese-style super-hospitals: black holes, pumps and the largest township hospitals from far away patients turned the "big" hospital into the railway station site of the Spring Festival, yellow cattle a few meters away at more than dozens or even hundreds of times the price to peddle the number source;
: there is a shortage of quality doctors in primary health care institutions.
" E drug manager" outbreak under the half-year results of multinational pharmaceutical companies are mixed, these drugs may become the number one? Up to now, Roche, Novarro, Johnson and Johnson and other 9 multinational pharmaceutical companies released the first half of 2020 results, overall, the median growth rate of 1.3%, significantly lower than the same period in 2019, it can be seen that the impact of the new crown epidemic is still continuing.
although the growth rate is not as good as before, but the drug enterprises, the growth rate of new drugs is obvious, is driving the performance growth of pharmaceutical enterprises can not be ignored.
headlines: the first half of 2020 is a "difficult time".
Siemens' $16.4 billion acquisition of Varian Genesis This year's biggest acquisition in the healthcare sector On August 2, 2020, Siemens Healthers of Germany confirmed that it would acquire Varian Medical Systems, a U.S. cancer medical technology maker, in an all-cash deal valued at $16.4 billion on a fully diluted basis.
: The radiotherapy market is growing rapidly.
the first 1 billion Chinese ointment paste was born TOP10 ranking bio-paste paste is a modern peeling agent, mainly used in the field of anti-inflammatory analgesics.
data show that in recent years, China's public medical institutions in the terminal of the paste market has grown steadily.
TOP10 product sales are more than 100 million yuan, orthopaedic painkillers accounted for half of the wall, Yunnan white ointment sales exceeded 1 billion scale, and pain relief paste followed closely;
headlines: Industry concentration may increase further.
do you want to live in a single pharmacy? Some people say that a mononone shop is weak in the word monosynth.
the procurement side bargaining power is weak, sales side sales are small, management side of the mobility of large, stores can not carry out institutionalized standardized training and services, even now there are some 020 platform do not accept them.
pharmaceutical retail pharmacies in the past have health insurance drugs to make money, now drug parity, online and offline integration, big business super and other cross-line robbery to sell drugs, you let the monogam shop how to live? Headline: It's not just elephants that can escape the storm.
27th, Nature Reviews drug discovery published an article entitled "mRNA vaccines: intellectual property landscape".
In order to better understand the intellectual property rights of mRNA vaccine development, this paper generates a detailed IP profile by reviewing and indexing U.S., European and international (patent cooperation treaty-covered) English patents and applications issued from January 2010 to April 2020.
: The space for growth in this area will grow exponentially.
IN a new study published July 23 in the journal Cancer Cell, researchers from the Massachusetts Institute of Technology and Harvard University described a series of structural changes in chromosomals that control the evolution of cancer cells.
study of lung tumors in mice, researchers identified 11 chromosome states (also known as eigome states) as cancer cells became more aggressive.
researchers believe runX2, a key molecule found in the more aggressive tumor cell chroma state, is associated with advanced lung cancer in humans and could be used as a biomarker to predict patient prognostication.
: RUNX-positive height foreshadows poor survival in lung cancer patients.
"Dandelion" A pharmaceutical enterprise GMP compliance check does not pass do not agree to resume production July 31, Anhui Provincial Drug Administration issued the "Anhui Province Drug Production Supervision and Inspection Information Notice (June 2020)", the inspection of five pharmaceutical enterprises was made public, including Wuhu Boying Pharmaceutical Technology Co., Ltd. applied for GMP compliance inspection (resumption of production), the inspection conclusion is not in line with the requirements, and issued a warning letter (not to resume production).
: GMP certificates have been withdrawn.
.